1. Home
  2. MDGL vs BRBR Comparison

MDGL vs BRBR Comparison

Compare MDGL & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • BRBR
  • Stock Information
  • Founded
  • MDGL 2011
  • BRBR 2019
  • Country
  • MDGL United States
  • BRBR United States
  • Employees
  • MDGL N/A
  • BRBR N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • BRBR Packaged Foods
  • Sector
  • MDGL Health Care
  • BRBR Consumer Staples
  • Exchange
  • MDGL Nasdaq
  • BRBR Nasdaq
  • Market Cap
  • MDGL 7.5B
  • BRBR 8.8B
  • IPO Year
  • MDGL N/A
  • BRBR 2019
  • Fundamental
  • Price
  • MDGL $323.98
  • BRBR $75.13
  • Analyst Decision
  • MDGL Buy
  • BRBR Buy
  • Analyst Count
  • MDGL 10
  • BRBR 17
  • Target Price
  • MDGL $354.75
  • BRBR $78.88
  • AVG Volume (30 Days)
  • MDGL 317.3K
  • BRBR 1.4M
  • Earning Date
  • MDGL 05-06-2025
  • BRBR 05-05-2025
  • Dividend Yield
  • MDGL N/A
  • BRBR N/A
  • EPS Growth
  • MDGL N/A
  • BRBR 72.45
  • EPS
  • MDGL N/A
  • BRBR 2.12
  • Revenue
  • MDGL $180,133,000.00
  • BRBR $2,098,700,000.00
  • Revenue This Year
  • MDGL $228.41
  • BRBR $18.27
  • Revenue Next Year
  • MDGL $73.44
  • BRBR $11.01
  • P/E Ratio
  • MDGL N/A
  • BRBR $35.43
  • Revenue Growth
  • MDGL N/A
  • BRBR 21.00
  • 52 Week Low
  • MDGL $189.00
  • BRBR $48.06
  • 52 Week High
  • MDGL $377.46
  • BRBR $80.67
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 45.41
  • BRBR 61.06
  • Support Level
  • MDGL $310.00
  • BRBR $72.50
  • Resistance Level
  • MDGL $350.50
  • BRBR $74.35
  • Average True Range (ATR)
  • MDGL 13.02
  • BRBR 1.82
  • MACD
  • MDGL -1.72
  • BRBR 0.83
  • Stochastic Oscillator
  • MDGL 34.52
  • BRBR 87.44

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About BRBR BellRing Brands Inc.

BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.

Share on Social Networks: